View our sources.
| # | Citation | Link | Source |
|---|---|---|---|
| 1 | Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. Monticciolo, Debra L. et al. Journal of the American College of Radiology, Volume 15, Issue 3, 408 – 414 . https://www.jacr.org/article/S1546-1440(17)31524-7/fulltext | View | American College of Radiology |
| American College of Radiology Breast Cancer Screening in Women at Higher-Than-Average Risk (PDF) | View | ||
| Supplemental Handout for American College of Radiology Breast Cancer Screening in Women at Higher-Than-Average Risk (PDF) | View | ||
| 2 | Breast cancer risk assessment tool SAS MACRO (Gail Model). National Cancer Institute. 2018. Retrieved September 21, 2022, from https://dceg.cancer.gov/tools/risk-assessment/bcrasasmacro | View | National Cancer Institute |
| 3 | Banegas MP, John EM, Slattery ML, Gomez SL, Yu M, LaCroix AZ, Pee D, Chlebowski RT, Hines LM, Thompson CA, Gail MH. Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women. JNCI 2016; 109. | View | Journal of the National Cancer Institute |
| 4 | Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, Anderson GL, Malone KE, Marchbanks PA, McCaskill-Stevens W, Norman SA, Simon MS, Spirtas R, Ursin G, Berstein L. Projecting individualized absolute invasive breast cancer risk in African American women. JNCI 2007; 99:1782-92 | View | Journal of the National Cancer Institute |
| 5 | Surveillance Research Program, National Cancer Institute. SEER*Explorer. Breast Cancer – 5-year age-adjusted incidence rates, 2015-2019, by race/ethnicity, female, all ages, all stages. Accessed on April 19, 2022. https://seer.cancer.gov/explorer/, 2022. | View | National Cancer Institute |
| 6 | John EM, Phipps AI, Hines LM, et al. Menstrual and reproductive characteristics and breast cancer risk by hormone receptor status and ethnicity: The Breast Cancer Etiology in Minorities study. Int J Cancer. 147(7):1808-1822, 2020. | View | Internal Journal of Cancer |
| 7 | Rosner B, Colditz GA and Willett WC. Reproductive risk factors in a prospective study of breast cancer: the Nurses’ Health Study. Am J Epidemiol. 139: 819-835, 1994. | View | American Journal of Epidemiology |
| 8 | National Cancer Institute. Genetics of breast and gynecologic cancers (PDQ®) – health professional version. https://www.cancer.gov/types/breast/hp/breast-ovarian-genetics-pdq, 2021. | View | National Cancer Institute |
| 9 | Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 353(3):229-37, 2005. | View | New England Journal of Medicine |
| 10 | Sabel MS and Collins LC. Atypia and lobular carcinoma in situ: high-risk lesions of the breast. In: Chagpar AB, Whitman G, Chen W, eds. UpToDate. Waltham, MA, UpToDate, 2021. | View | UpToDate |
| 11 | Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 317(23):2402-2416, 2017 | View | JAMA |
| 12 | Moskowitz CS, Chou JF, Wolden SL, et al. Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol. 32(21):2217-23, 2014. | View | Journal of Clinical Oncology |
| 13 | Surveillance Research Program, National Cancer Institute. SEER*Explorer. Breast cancer- Comparison of cancer risk, 2017-2019, by risk type and risk interval, female, all races, risk from age 0. Accessed on September 21, 2022 | View | National Cancer Institute |
| 14 | Breast Cancer in Men. (2018). In New England Journal of Medicine (Vol. 379, Issue 14, pp. 1385–1386). Massachusetts Medical Society. https://doi.org/10.1056/nejmc1809194 | View | New England Journal of Medicine |
| 15 | BRCA gene mutations: Cancer risk and Genetic Testing Fact Sheet. National Cancer Institute. Retrieved September 21, 2022, from https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet | View | National Cancer Institute |
| 16 | Risk factors for breast cancer in men. American Cancer Society. Retrieved September 21, 2022, from https://www.cancer.org/cancer/breast-cancer-in-men/causes-risks-prevention/risk-factors.html | View | National Cancer Institute |
| 17 | Hyuna Sung, Carol DeSantis, Ahmedin Jemal, Subtype-Specific Breast Cancer Incidence Rates in Black versus White Men in the United States, JNCI Cancer Spectrum, Volume 4, Issue 1, February 2020, pkz091, https://doi.org/10.1093/jncics/pkz091 | View | Journal of the National Cancer Institute |
| 18 | Woods RW, Salkowski LR, Elezaby M, Burnside ES, Strigel RM, Fowler AM. Image-based screening for men at high risk for breast cancer: Benefits and drawbacks. Clin Imaging. 2020 Mar;60(1):84-89. doi: 10.1016/j.clinimag.2019.11.005. Epub 2019 Nov 28. PMID: 31864206; PMCID: PMC7242122. https://pubmed.ncbi.nlm.nih.gov/31864206/ | View | Clinical Imaging |
| 19 | National Comprehensive Cancer Network. (2022). BRCA-Pathogenic/Likely Pathogenic Variant – Positive Management (version 2.2022). Retrieved from https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf | View | NCCN |
| 20 | Key statistics for breast cancer in men. American Cancer Society. Retrieved September 21, 2022, from https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html | View | National Cancer Institute |
| 21 | ACR Appropriateness Criteria® Transgender Breast Cancer Screening Brown, Ann et al. Journal of the American College of Radiology, Volume 18, Issue 11, S502 - S515. https://doi.org/10.1016/j.jacr.2021.09.005 | View | American College of Radiology |
| Patient-Friendly Summary of the ACR Appropriateness Criteria: Transgender Breast Cancer Screening | View | ||
| 22 | American Psychological Association. (2015). Guidelines for Psychological Practice with Transgender and Gender Nonconforming People. American Psychologist, 70 (9), 832-864. doi: 10.1037/a0039906 | View | American Psychological Association |
| 23 | de Blok C J M, Wiepjes C M, Nota N M, van Engelen K, Adank M A, Dreijerink K M A et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands BMJ 2019; 365 :l1652 doi:10.1136/bmj.l1652 | View | BMJ |
| 24 | Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M. Cancer in Transgender People: Evidence and Methodological Considerations. Epidemiol Rev2017;39:93-107. doi:10.1093/epirev/mxw003. pmid:28486701 | View | Epidemiologic Reviews |
| 25 | Mulder RL, Kremer LC, Hudson MM, Bhatia S, Landier W, Levitt G, Constine LS, Wallace WH, van Leeuwen FE, Ronckers CM, Henderson TO, Dwyer M, Skinner R, Oeffinger KC; International Late Effects of Childhood Cancer Guideline Harmonization Group. Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2013 Dec;14(13):e621-9. doi: 10.1016/S1470-2045(13)70303-6. PMID: 24275135; PMCID: PMC4257601. | View | Lancet Oncology |
Last Updated
Information on this page was last updated on September 29, 2022.